nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2C9—brain cancer	0.76	1	CbGaD
Prasugrel—CYP3A4—Temozolomide—brain cancer	0.0375	0.487	CbGbCtD
Prasugrel—CYP3A4—Lomustine—brain cancer	0.0319	0.414	CbGbCtD
Prasugrel—CES2—Phase I biotransformations, non P450—PON1—brain cancer	0.0175	0.27	CbGpPWpGaD
Prasugrel—CYP3A4—Etoposide—brain cancer	0.0077	0.1	CbGbCtD
Prasugrel—Retinal haemorrhage—Procarbazine—brain cancer	0.00594	0.0665	CcSEcCtD
Prasugrel—Clopidogrel—CYP2C9—brain cancer	0.00509	1	CrCbGaD
Prasugrel—CES2—E2F transcription factor network—HIC1—brain cancer	0.00508	0.0782	CbGpPWpGaD
Prasugrel—Retinal haemorrhage—Carmustine—brain cancer	0.00372	0.0416	CcSEcCtD
Prasugrel—Contusion—Lomustine—brain cancer	0.0035	0.0391	CcSEcCtD
Prasugrel—CES2—Irinotecan Pathway—APC—brain cancer	0.0029	0.0446	CbGpPWpGaD
Prasugrel—Haemorrhage intracranial—Temozolomide—brain cancer	0.00285	0.032	CcSEcCtD
Prasugrel—Neoplasm—Lomustine—brain cancer	0.00276	0.0309	CcSEcCtD
Prasugrel—Haemoptysis—Procarbazine—brain cancer	0.00262	0.0293	CcSEcCtD
Prasugrel—Neoplasm malignant—Procarbazine—brain cancer	0.00227	0.0254	CcSEcCtD
Prasugrel—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00227	0.0349	CbGpPWpGaD
Prasugrel—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00221	0.034	CbGpPWpGaD
Prasugrel—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00201	0.031	CbGpPWpGaD
Prasugrel—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00171	0.0264	CbGpPWpGaD
Prasugrel—Haemoglobin—Lomustine—brain cancer	0.00154	0.0172	CcSEcCtD
Prasugrel—Haemorrhage—Lomustine—brain cancer	0.00153	0.0171	CcSEcCtD
Prasugrel—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00141	0.0216	CbGpPWpGaD
Prasugrel—Neoplasm—Hydroxyurea—brain cancer	0.00136	0.0152	CcSEcCtD
Prasugrel—Leukopenia—Lomustine—brain cancer	0.00119	0.0134	CcSEcCtD
Prasugrel—Neoplasm—Carmustine—brain cancer	0.0011	0.0123	CcSEcCtD
Prasugrel—CES2—E2F transcription factor network—SIRT1—brain cancer	0.00109	0.0167	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CCNE1—brain cancer	0.00107	0.0165	CbGpPWpGaD
Prasugrel—Thrombocytopenia—Lomustine—brain cancer	0.00107	0.0119	CcSEcCtD
Prasugrel—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00106	0.0163	CbGpPWpGaD
Prasugrel—Neoplasm—Temozolomide—brain cancer	0.00106	0.0119	CcSEcCtD
Prasugrel—Haematuria—Procarbazine—brain cancer	0.00103	0.0116	CcSEcCtD
Prasugrel—Epistaxis—Procarbazine—brain cancer	0.00102	0.0114	CcSEcCtD
Prasugrel—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00102	0.0157	CbGpPWpGaD
Prasugrel—Body temperature increased—Carboplatin—brain cancer	0.000983	0.011	CcSEcCtD
Prasugrel—Haemoglobin—Procarbazine—brain cancer	0.000978	0.0109	CcSEcCtD
Prasugrel—Haemorrhage—Procarbazine—brain cancer	0.000973	0.0109	CcSEcCtD
Prasugrel—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000965	0.0149	CbGpPWpGaD
Prasugrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000919	0.0142	CbGpPWpGaD
Prasugrel—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00088	0.00985	CcSEcCtD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000878	0.0135	CbGpPWpGaD
Prasugrel—Body temperature increased—Lomustine—brain cancer	0.00086	0.00963	CcSEcCtD
Prasugrel—Anaemia—Procarbazine—brain cancer	0.000783	0.00876	CcSEcCtD
Prasugrel—Leukopenia—Procarbazine—brain cancer	0.000758	0.00848	CcSEcCtD
Prasugrel—Haemoglobin—Hydroxyurea—brain cancer	0.000757	0.00847	CcSEcCtD
Prasugrel—Haemorrhage—Hydroxyurea—brain cancer	0.000753	0.00843	CcSEcCtD
Prasugrel—Cough—Procarbazine—brain cancer	0.000739	0.00827	CcSEcCtD
Prasugrel—Hypertension—Procarbazine—brain cancer	0.000731	0.00818	CcSEcCtD
Prasugrel—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000729	0.0112	CbGpPWpGaD
Prasugrel—Angiopathy—Hydroxyurea—brain cancer	0.000683	0.00764	CcSEcCtD
Prasugrel—Thrombocytopenia—Procarbazine—brain cancer	0.000677	0.00757	CcSEcCtD
Prasugrel—CES2—Fluoropyrimidine Activity—TP53—brain cancer	0.000659	0.0102	CbGpPWpGaD
Prasugrel—Nausea—Lomustine—brain cancer	0.000646	0.00724	CcSEcCtD
Prasugrel—Hypotension—Procarbazine—brain cancer	0.000646	0.00723	CcSEcCtD
Prasugrel—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000639	0.00983	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDKN2A—brain cancer	0.000628	0.00966	CbGpPWpGaD
Prasugrel—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000614	0.00946	CbGpPWpGaD
Prasugrel—Haemoglobin—Carmustine—brain cancer	0.000612	0.00685	CcSEcCtD
Prasugrel—Haemorrhage—Carmustine—brain cancer	0.000608	0.00681	CcSEcCtD
Prasugrel—Anaemia—Hydroxyurea—brain cancer	0.000606	0.00678	CcSEcCtD
Prasugrel—Oedema peripheral—Carmustine—brain cancer	0.000599	0.00671	CcSEcCtD
Prasugrel—Fatigue—Procarbazine—brain cancer	0.000596	0.00667	CcSEcCtD
Prasugrel—Haemoglobin—Temozolomide—brain cancer	0.000591	0.00662	CcSEcCtD
Prasugrel—Haemorrhage—Temozolomide—brain cancer	0.000588	0.00658	CcSEcCtD
Prasugrel—Leukopenia—Hydroxyurea—brain cancer	0.000587	0.00657	CcSEcCtD
Prasugrel—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000583	0.00898	CbGpPWpGaD
Prasugrel—Urinary tract disorder—Temozolomide—brain cancer	0.000581	0.0065	CcSEcCtD
Prasugrel—Oedema peripheral—Temozolomide—brain cancer	0.000579	0.00648	CcSEcCtD
Prasugrel—Urethral disorder—Temozolomide—brain cancer	0.000576	0.00645	CcSEcCtD
Prasugrel—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000576	0.00887	CbGpPWpGaD
Prasugrel—Eye disorder—Carmustine—brain cancer	0.000569	0.00637	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000554	0.0062	CcSEcCtD
Prasugrel—Eye disorder—Temozolomide—brain cancer	0.00055	0.00615	CcSEcCtD
Prasugrel—Body temperature increased—Procarbazine—brain cancer	0.000546	0.00611	CcSEcCtD
Prasugrel—Angiopathy—Temozolomide—brain cancer	0.000534	0.00597	CcSEcCtD
Prasugrel—Immune system disorder—Temozolomide—brain cancer	0.000531	0.00595	CcSEcCtD
Prasugrel—Mediastinal disorder—Temozolomide—brain cancer	0.00053	0.00593	CcSEcCtD
Prasugrel—Thrombocytopenia—Hydroxyurea—brain cancer	0.000524	0.00586	CcSEcCtD
Prasugrel—Skin disorder—Hydroxyurea—brain cancer	0.000519	0.00581	CcSEcCtD
Prasugrel—Back pain—Carmustine—brain cancer	0.000512	0.00574	CcSEcCtD
Prasugrel—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00051	0.00786	CbGpPWpGaD
Prasugrel—Hypersensitivity—Procarbazine—brain cancer	0.000509	0.0057	CcSEcCtD
Prasugrel—Asthenia—Procarbazine—brain cancer	0.000496	0.00555	CcSEcCtD
Prasugrel—Back pain—Temozolomide—brain cancer	0.000495	0.00554	CcSEcCtD
Prasugrel—Anaemia—Carmustine—brain cancer	0.00049	0.00548	CcSEcCtD
Prasugrel—Dyspnoea—Hydroxyurea—brain cancer	0.000477	0.00534	CcSEcCtD
Prasugrel—Leukopenia—Carmustine—brain cancer	0.000474	0.00531	CcSEcCtD
Prasugrel—Anaemia—Temozolomide—brain cancer	0.000473	0.0053	CcSEcCtD
Prasugrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000473	0.00728	CbGpPWpGaD
Prasugrel—Diarrhoea—Procarbazine—brain cancer	0.000473	0.00529	CcSEcCtD
Prasugrel—Angioedema—Temozolomide—brain cancer	0.000468	0.00524	CcSEcCtD
Prasugrel—Urinary tract disorder—Etoposide—brain cancer	0.000465	0.0052	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000462	0.00517	CcSEcCtD
Prasugrel—Urethral disorder—Etoposide—brain cancer	0.000461	0.00516	CcSEcCtD
Prasugrel—Fatigue—Hydroxyurea—brain cancer	0.000461	0.00516	CcSEcCtD
Prasugrel—Leukopenia—Temozolomide—brain cancer	0.000458	0.00513	CcSEcCtD
Prasugrel—Hypertension—Carmustine—brain cancer	0.000457	0.00512	CcSEcCtD
Prasugrel—Dizziness—Procarbazine—brain cancer	0.000457	0.00512	CcSEcCtD
Prasugrel—P2RY12—Hemostasis—MPL—brain cancer	0.000452	0.00697	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—PTCH2—brain cancer	0.000451	0.00694	CbGpPWpGaD
Prasugrel—Cough—Temozolomide—brain cancer	0.000447	0.005	CcSEcCtD
Prasugrel—Hypertension—Temozolomide—brain cancer	0.000442	0.00495	CcSEcCtD
Prasugrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000441	0.00679	CbGpPWpGaD
Prasugrel—Eye disorder—Etoposide—brain cancer	0.00044	0.00492	CcSEcCtD
Prasugrel—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000438	0.00675	CbGpPWpGaD
Prasugrel—Rash—Procarbazine—brain cancer	0.000436	0.00488	CcSEcCtD
Prasugrel—Dermatitis—Procarbazine—brain cancer	0.000435	0.00487	CcSEcCtD
Prasugrel—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000435	0.0067	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—S100A10—brain cancer	0.000434	0.00668	CbGpPWpGaD
Prasugrel—Headache—Procarbazine—brain cancer	0.000433	0.00485	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000433	0.00484	CcSEcCtD
Prasugrel—Angiopathy—Etoposide—brain cancer	0.000427	0.00478	CcSEcCtD
Prasugrel—CES2—E2F transcription factor network—MYC—brain cancer	0.000425	0.00655	CbGpPWpGaD
Prasugrel—Immune system disorder—Etoposide—brain cancer	0.000425	0.00476	CcSEcCtD
Prasugrel—Mediastinal disorder—Etoposide—brain cancer	0.000424	0.00475	CcSEcCtD
Prasugrel—Thrombocytopenia—Carmustine—brain cancer	0.000423	0.00474	CcSEcCtD
Prasugrel—Body temperature increased—Hydroxyurea—brain cancer	0.000423	0.00473	CcSEcCtD
Prasugrel—Anaphylactic shock—Temozolomide—brain cancer	0.000418	0.00468	CcSEcCtD
Prasugrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000418	0.00643	CbGpPWpGaD
Prasugrel—Nausea—Procarbazine—brain cancer	0.00041	0.00459	CcSEcCtD
Prasugrel—Thrombocytopenia—Temozolomide—brain cancer	0.000409	0.00458	CcSEcCtD
Prasugrel—Skin disorder—Temozolomide—brain cancer	0.000406	0.00454	CcSEcCtD
Prasugrel—Hypotension—Carmustine—brain cancer	0.000404	0.00452	CcSEcCtD
Prasugrel—Back pain—Etoposide—brain cancer	0.000396	0.00444	CcSEcCtD
Prasugrel—P2RY12—GPCR downstream signaling—OR4C12—brain cancer	0.000395	0.00609	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—OR14C36—brain cancer	0.000395	0.00609	CbGpPWpGaD
Prasugrel—Hypersensitivity—Hydroxyurea—brain cancer	0.000394	0.00441	CcSEcCtD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000389	0.00598	CbGpPWpGaD
Prasugrel—Dyspnoea—Carmustine—brain cancer	0.000385	0.00431	CcSEcCtD
Prasugrel—Asthenia—Hydroxyurea—brain cancer	0.000384	0.0043	CcSEcCtD
Prasugrel—Anaemia—Etoposide—brain cancer	0.000379	0.00424	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Carmustine—brain cancer	0.000373	0.00418	CcSEcCtD
Prasugrel—Dyspnoea—Temozolomide—brain cancer	0.000372	0.00417	CcSEcCtD
Prasugrel—Leukopenia—Etoposide—brain cancer	0.000367	0.0041	CcSEcCtD
Prasugrel—Diarrhoea—Hydroxyurea—brain cancer	0.000366	0.0041	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Temozolomide—brain cancer	0.000361	0.00404	CcSEcCtD
Prasugrel—Fatigue—Temozolomide—brain cancer	0.00036	0.00403	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—OR14C36—brain cancer	0.000359	0.00553	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—OR4C12—brain cancer	0.000359	0.00553	CbGpPWpGaD
Prasugrel—Cough—Etoposide—brain cancer	0.000357	0.004	CcSEcCtD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000357	0.0055	CbGpPWpGaD
Prasugrel—Hypertension—Etoposide—brain cancer	0.000354	0.00396	CcSEcCtD
Prasugrel—Dizziness—Hydroxyurea—brain cancer	0.000354	0.00396	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000346	0.00388	CcSEcCtD
Prasugrel—Body temperature increased—Carmustine—brain cancer	0.000342	0.00383	CcSEcCtD
Prasugrel—Rash—Hydroxyurea—brain cancer	0.000337	0.00377	CcSEcCtD
Prasugrel—Dermatitis—Hydroxyurea—brain cancer	0.000337	0.00377	CcSEcCtD
Prasugrel—Headache—Hydroxyurea—brain cancer	0.000335	0.00375	CcSEcCtD
Prasugrel—Anaphylactic shock—Etoposide—brain cancer	0.000334	0.00374	CcSEcCtD
Prasugrel—Body temperature increased—Temozolomide—brain cancer	0.00033	0.0037	CcSEcCtD
Prasugrel—Thrombocytopenia—Etoposide—brain cancer	0.000327	0.00366	CcSEcCtD
Prasugrel—Skin disorder—Etoposide—brain cancer	0.000325	0.00363	CcSEcCtD
Prasugrel—Hypersensitivity—Carmustine—brain cancer	0.000319	0.00357	CcSEcCtD
Prasugrel—Nausea—Hydroxyurea—brain cancer	0.000318	0.00356	CcSEcCtD
Prasugrel—Hypotension—Etoposide—brain cancer	0.000312	0.0035	CcSEcCtD
Prasugrel—Asthenia—Carmustine—brain cancer	0.00031	0.00347	CcSEcCtD
Prasugrel—Hypersensitivity—Temozolomide—brain cancer	0.000308	0.00345	CcSEcCtD
Prasugrel—P2RY12—Hemostasis—BSG—brain cancer	0.000306	0.00471	CbGpPWpGaD
Prasugrel—CES2—telencephalon—brain cancer	0.000301	0.0743	CbGeAlD
Prasugrel—Asthenia—Temozolomide—brain cancer	0.0003	0.00336	CcSEcCtD
Prasugrel—Dyspnoea—Etoposide—brain cancer	0.000298	0.00334	CcSEcCtD
Prasugrel—P2RY12—endocrine gland—brain cancer	0.000297	0.0734	CbGeAlD
Prasugrel—Diarrhoea—Carmustine—brain cancer	0.000296	0.00331	CcSEcCtD
Prasugrel—P2RY12—head—brain cancer	0.000293	0.0725	CbGeAlD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000291	0.00448	CbGpPWpGaD
Prasugrel—Gastrointestinal disorder—Etoposide—brain cancer	0.000289	0.00323	CcSEcCtD
Prasugrel—Fatigue—Etoposide—brain cancer	0.000288	0.00323	CcSEcCtD
Prasugrel—Dizziness—Carmustine—brain cancer	0.000286	0.0032	CcSEcCtD
Prasugrel—Diarrhoea—Temozolomide—brain cancer	0.000286	0.0032	CcSEcCtD
Prasugrel—Dizziness—Temozolomide—brain cancer	0.000276	0.00309	CcSEcCtD
Prasugrel—Rash—Carmustine—brain cancer	0.000273	0.00305	CcSEcCtD
Prasugrel—Dermatitis—Carmustine—brain cancer	0.000272	0.00305	CcSEcCtD
Prasugrel—Headache—Carmustine—brain cancer	0.000271	0.00303	CcSEcCtD
Prasugrel—P2RY12—central nervous system—brain cancer	0.000268	0.0662	CbGeAlD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000265	0.00408	CbGpPWpGaD
Prasugrel—Body temperature increased—Etoposide—brain cancer	0.000264	0.00296	CcSEcCtD
Prasugrel—Rash—Temozolomide—brain cancer	0.000263	0.00295	CcSEcCtD
Prasugrel—Dermatitis—Temozolomide—brain cancer	0.000263	0.00295	CcSEcCtD
Prasugrel—Headache—Temozolomide—brain cancer	0.000262	0.00293	CcSEcCtD
Prasugrel—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000262	0.00403	CbGpPWpGaD
Prasugrel—Nausea—Carmustine—brain cancer	0.000257	0.00287	CcSEcCtD
Prasugrel—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000251	0.00387	CbGpPWpGaD
Prasugrel—CES2—gonad—brain cancer	0.000251	0.062	CbGeAlD
Prasugrel—Nausea—Temozolomide—brain cancer	0.000248	0.00278	CcSEcCtD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000248	0.00382	CbGpPWpGaD
Prasugrel—Hypersensitivity—Etoposide—brain cancer	0.000246	0.00276	CcSEcCtD
Prasugrel—CES2—pituitary gland—brain cancer	0.000245	0.0605	CbGeAlD
Prasugrel—Asthenia—Etoposide—brain cancer	0.00024	0.00268	CcSEcCtD
Prasugrel—CES2—medulla oblongata—brain cancer	0.000236	0.0583	CbGeAlD
Prasugrel—P2RY12—GPCR ligand binding—SHH—brain cancer	0.000232	0.00358	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PTCH2—brain cancer	0.000231	0.00356	CbGpPWpGaD
Prasugrel—Diarrhoea—Etoposide—brain cancer	0.000229	0.00256	CcSEcCtD
Prasugrel—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000225	0.00347	CbGpPWpGaD
Prasugrel—Dizziness—Etoposide—brain cancer	0.000221	0.00247	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—SMO—brain cancer	0.00022	0.00339	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—PTCH1—brain cancer	0.00022	0.00339	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000218	0.00335	CbGpPWpGaD
Prasugrel—CES2—midbrain—brain cancer	0.000216	0.0533	CbGeAlD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000215	0.00331	CbGpPWpGaD
Prasugrel—P2RY12—brain—brain cancer	0.000213	0.0525	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—OR14C36—brain cancer	0.000212	0.00327	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—OR4C12—brain cancer	0.000212	0.00327	CbGpPWpGaD
Prasugrel—Rash—Etoposide—brain cancer	0.000211	0.00236	CcSEcCtD
Prasugrel—CES2—spinal cord—brain cancer	0.000211	0.052	CbGeAlD
Prasugrel—Dermatitis—Etoposide—brain cancer	0.000211	0.00236	CcSEcCtD
Prasugrel—Headache—Etoposide—brain cancer	0.000209	0.00234	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.0002	0.00309	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TRPC6—brain cancer	0.0002	0.00308	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—ABR—brain cancer	0.0002	0.00308	CbGpPWpGaD
Prasugrel—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.0002	0.00308	CbGpPWpGaD
Prasugrel—Nausea—Etoposide—brain cancer	0.000199	0.00222	CcSEcCtD
Prasugrel—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.00019	0.00292	CbGpPWpGaD
Prasugrel—CES2—endocrine gland—brain cancer	0.00019	0.0468	CbGeAlD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000187	0.00288	CbGpPWpGaD
Prasugrel—CES2—head—brain cancer	0.000187	0.0462	CbGeAlD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000185	0.00285	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—ABR—brain cancer	0.000182	0.0028	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—DTX2—brain cancer	0.00018	0.00278	CbGpPWpGaD
Prasugrel—CES2—central nervous system—brain cancer	0.000171	0.0422	CbGeAlD
Prasugrel—CES2—cerebellum—brain cancer	0.000167	0.0413	CbGeAlD
Prasugrel—ALB—Folate Metabolism—SOD2—brain cancer	0.000163	0.00251	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—VAV1—brain cancer	0.00015	0.00231	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTCH2—brain cancer	0.000137	0.00211	CbGpPWpGaD
Prasugrel—CES2—brain—brain cancer	0.000136	0.0335	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—HES5—brain cancer	0.000132	0.00204	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—IL2—brain cancer	0.00013	0.002	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.00013	0.002	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STRADA—brain cancer	0.000129	0.00198	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—TRPC6—brain cancer	0.000127	0.00195	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—SHH—brain cancer	0.000119	0.00184	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000116	0.00178	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—TRPC6—brain cancer	0.000115	0.00177	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000114	0.00176	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PTCH1—brain cancer	0.000113	0.00174	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—SMO—brain cancer	0.000113	0.00174	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000113	0.00173	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MPL—brain cancer	0.000112	0.00173	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000111	0.0017	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—S100A10—brain cancer	0.000108	0.00166	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ABR—brain cancer	0.000107	0.00165	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GLI2—brain cancer	0.000104	0.0016	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GLI1—brain cancer	9.74e-05	0.0015	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.65e-05	0.00149	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CG—brain cancer	9.53e-05	0.00147	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—VAV1—brain cancer	9.48e-05	0.00146	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—RELA—brain cancer	9.43e-05	0.00145	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	9.32e-05	0.00144	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SUFU—brain cancer	9.23e-05	0.00142	CbGpPWpGaD
Prasugrel—CYP2B6—gonad—brain cancer	9.05e-05	0.0224	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—GFAP—brain cancer	8.91e-05	0.00137	CbGpPWpGaD
Prasugrel—CYP2C19—endocrine gland—brain cancer	8.74e-05	0.0216	CbGeAlD
Prasugrel—P2RY12—Signaling by GPCR—VAV1—brain cancer	8.61e-05	0.00133	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL2—brain cancer	8.49e-05	0.00131	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HEY1—brain cancer	8.45e-05	0.0013	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—DLL1—brain cancer	8.28e-05	0.00128	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.12e-05	0.00125	CbGpPWpGaD
Prasugrel—ALB—brain—brain cancer	7.76e-05	0.0192	CbGeAlD
Prasugrel—ALB—Hemostasis—BSG—brain cancer	7.59e-05	0.00117	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—RELA—brain cancer	7.49e-05	0.00115	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.29e-05	0.00112	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	7.23e-05	0.00111	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SHH—brain cancer	7.04e-05	0.00108	CbGpPWpGaD
Prasugrel—CYP2B6—endocrine gland—brain cancer	6.84e-05	0.0169	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—TRPC6—brain cancer	6.79e-05	0.00105	CbGpPWpGaD
Prasugrel—CYP2C9—endocrine gland—brain cancer	6.78e-05	0.0167	CbGeAlD
Prasugrel—CYP2B6—head—brain cancer	6.75e-05	0.0167	CbGeAlD
Prasugrel—P2RY12—Hemostasis—IL2—brain cancer	6.71e-05	0.00103	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTCH1—brain cancer	6.68e-05	0.00103	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SMO—brain cancer	6.68e-05	0.00103	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—VEGFA—brain cancer	6.19e-05	0.000953	CbGpPWpGaD
Prasugrel—CYP2B6—central nervous system—brain cancer	6.17e-05	0.0152	CbGeAlD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CG—brain cancer	6.02e-05	0.000927	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.94e-05	0.000914	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	5.89e-05	0.000908	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—VEGFA—brain cancer	5.7e-05	0.000878	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CG—brain cancer	5.47e-05	0.000842	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—brain cancer	5.45e-05	0.00084	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOTCH2—brain cancer	5.34e-05	0.000822	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.33e-05	0.000821	CbGpPWpGaD
Prasugrel—CYP3A4—endocrine gland—brain cancer	5.17e-05	0.0128	CbGeAlD
Prasugrel—P2RY12—Signaling Pathways—VAV1—brain cancer	5.09e-05	0.000783	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TRPC6—brain cancer	4.97e-05	0.000766	CbGpPWpGaD
Prasugrel—CYP2B6—brain—brain cancer	4.89e-05	0.0121	CbGeAlD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.86e-05	0.000748	CbGpPWpGaD
Prasugrel—CYP3A4—central nervous system—brain cancer	4.66e-05	0.0115	CbGeAlD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.59e-05	0.000707	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HES1—brain cancer	4.38e-05	0.000674	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—brain cancer	4.31e-05	0.000663	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	4.3e-05	0.000663	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2C9—brain cancer	4.3e-05	0.000662	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—IL2—brain cancer	4.24e-05	0.000653	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PDGFRA—brain cancer	4.17e-05	0.000642	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SPP1—brain cancer	4.04e-05	0.000623	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL2—brain cancer	3.85e-05	0.000593	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VAV1—brain cancer	3.73e-05	0.000574	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IRS2—brain cancer	3.66e-05	0.000563	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BSG—brain cancer	3.65e-05	0.000563	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2C9—brain cancer	3.62e-05	0.000557	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2C9—brain cancer	3.25e-05	0.0005	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CG—brain cancer	3.23e-05	0.000497	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APC—brain cancer	3.23e-05	0.000497	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	3.23e-05	0.000497	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—IDH1—brain cancer	3.14e-05	0.000484	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BSG—brain cancer	3.08e-05	0.000474	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—brain cancer	2.94e-05	0.000453	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BSG—brain cancer	2.76e-05	0.000425	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.74e-05	0.000423	CbGpPWpGaD
Prasugrel—ALB—Metabolism—IDH1—brain cancer	2.64e-05	0.000407	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RELA—brain cancer	2.52e-05	0.000389	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BSG—brain cancer	2.52e-05	0.000388	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB2—brain cancer	2.51e-05	0.000386	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ENO2—brain cancer	2.48e-05	0.000382	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—IDH1—brain cancer	2.37e-05	0.000366	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—brain cancer	2.37e-05	0.000364	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—brain cancer	2.27e-05	0.00035	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—brain cancer	2.22e-05	0.000341	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNB1—brain cancer	2.19e-05	0.000338	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—IDH1—brain cancer	2.16e-05	0.000333	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.15e-05	0.000332	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ENO2—brain cancer	2.09e-05	0.000322	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2C9—brain cancer	1.95e-05	0.000301	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.93e-05	0.000298	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—brain cancer	1.93e-05	0.000298	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—brain cancer	1.91e-05	0.000295	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ENO2—brain cancer	1.88e-05	0.000289	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—brain cancer	1.78e-05	0.000274	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.76e-05	0.000271	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—brain cancer	1.74e-05	0.000268	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ENO2—brain cancer	1.71e-05	0.000263	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—brain cancer	1.66e-05	0.000256	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BSG—brain cancer	1.66e-05	0.000256	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—brain cancer	1.46e-05	0.000225	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—IDH1—brain cancer	1.43e-05	0.00022	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—brain cancer	1.41e-05	0.000218	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ENO2—brain cancer	1.13e-05	0.000174	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—brain cancer	1.07e-05	0.000165	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—brain cancer	9.59e-06	0.000148	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—brain cancer	8.61e-06	0.000133	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—brain cancer	7.85e-06	0.000121	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—brain cancer	5.18e-06	7.97e-05	CbGpPWpGaD
